Stay updated on M7824 and Eribulin in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.

Latest updates to the M7824 and Eribulin in Metastatic TNBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3, indicating a site release update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check25 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No content or study data were altered.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedThe revision number updated from v3.4.1 to v3.4.2. No substantive content or public-facing information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check96 days agoChange DetectedOnly a site version label in the footer updated from v3.4.0 to v3.4.1; no study details, eligibility criteria, or other content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to M7824 and Eribulin in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.